“If you have ovarian cancer, ask your oncologistto consider a test that will help determine whether your cancer is one of just under 50 per cent that might be responsive to new treatment options such as PARPinhibitors.” That’s the message from ovarian cancer researcher Professor Anna deFazio from The Westmead Institute for Medical Research (WIMR)…
Sydney, Australia, Wednesday, 1 May 2024 – Illumina, Inc. (NASDAQ: ILMN) With researchers, The Hon. David Harris MP, NSW Minister for Medical Research, Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research’s TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, with…
71 per cent of Australians believe that gene testing does not necessarily contribute to effective cancer or disease treatment according to a survey by Lonergan on behalf of gene technology company, Illumina.
Media release from the Australian Alliance for Indigenous Genomics (ALIGN) A national alliance of the brightest minds in genomic science, academia, policy makers, industry and Indigenous leaders will work to break down barriers to ensure Aboriginal and Torres Strait Islander people can benefit from advances in genomic medicine if they choose. The Australian Alliance for…